Steve Brozak
Stock Analyst at WBB Securities
(0)
# 5305
Out of 5,333 analysts
13
Total ratings
0.00%
Success rate
-80.49%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRKR Marker Therapeutics | Reiterates: Strong Buy | 13 13 | 1.17 | 968.38% | 1 | Apr 1, 2025 | |
CFRX ContraFect | Upgrades: Strong Buy | 560 | n/a | n/a | 3 | Jun 8, 2022 | |
PRTK Paratek Pharmaceuticals | Upgrades: Strong Buy | 11 | n/a | n/a | 2 | Feb 10, 2022 | |
CDTX Cidara Therapeutics | Upgrades: Strong Buy | n/a | n/a | n/a | 1 | Sep 22, 2021 | |
CWBR CohBar | Upgrades: Buy | 150 | n/a | n/a | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 75 100 | 6.17 | 1520.75% | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Buy | 17000 16000 | 1.99 | 803920.1% | 3 | May 28, 2021 |